Cargando…
Emerging issues in probiotic safety: 2023 perspectives
Probiotics are used for both generally healthy consumers and in clinical settings. However, theoretical and proven adverse events from probiotic consumption exist. New probiotic strains and products, as well as expanding use of probiotics into vulnerable populations, warrants concise, and actionable...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026873/ https://www.ncbi.nlm.nih.gov/pubmed/36919522 http://dx.doi.org/10.1080/19490976.2023.2185034 |
_version_ | 1784909605648728064 |
---|---|
author | Merenstein, Daniel Pot, Bruno Leyer, Gregory Ouwehand, Arthur C. Preidis, Geoffrey A. Elkins, Christopher A. Hill, Colin Lewis, Zachery T. Shane, Andi L. Zmora, Niv Petrova, Mariya I. Collado, Maria Carmen Morelli, Lorenzo Montoya, Gina A. Szajewska, Hania Tancredi, Daniel J. Sanders, Mary Ellen |
author_facet | Merenstein, Daniel Pot, Bruno Leyer, Gregory Ouwehand, Arthur C. Preidis, Geoffrey A. Elkins, Christopher A. Hill, Colin Lewis, Zachery T. Shane, Andi L. Zmora, Niv Petrova, Mariya I. Collado, Maria Carmen Morelli, Lorenzo Montoya, Gina A. Szajewska, Hania Tancredi, Daniel J. Sanders, Mary Ellen |
author_sort | Merenstein, Daniel |
collection | PubMed |
description | Probiotics are used for both generally healthy consumers and in clinical settings. However, theoretical and proven adverse events from probiotic consumption exist. New probiotic strains and products, as well as expanding use of probiotics into vulnerable populations, warrants concise, and actionable recommendations on how to work toward their safe and effective use. The International Scientific Association for Probiotics and Prebiotics convened a meeting to discuss and produce evidence-based recommendations on potential acute and long-term risks, risks to vulnerable populations, the importance for probiotic product quality to match the needs of vulnerable populations, and the need for adverse event reporting related to probiotic use. The importance of whole genome sequencing, which enables determination of virulence, toxin, and antibiotic resistance genes, as well as clear assignment of species and strain identity, is emphasized. We present recommendations to guide the scientific and medical community on judging probiotic safety. |
format | Online Article Text |
id | pubmed-10026873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-100268732023-03-21 Emerging issues in probiotic safety: 2023 perspectives Merenstein, Daniel Pot, Bruno Leyer, Gregory Ouwehand, Arthur C. Preidis, Geoffrey A. Elkins, Christopher A. Hill, Colin Lewis, Zachery T. Shane, Andi L. Zmora, Niv Petrova, Mariya I. Collado, Maria Carmen Morelli, Lorenzo Montoya, Gina A. Szajewska, Hania Tancredi, Daniel J. Sanders, Mary Ellen Gut Microbes Review Probiotics are used for both generally healthy consumers and in clinical settings. However, theoretical and proven adverse events from probiotic consumption exist. New probiotic strains and products, as well as expanding use of probiotics into vulnerable populations, warrants concise, and actionable recommendations on how to work toward their safe and effective use. The International Scientific Association for Probiotics and Prebiotics convened a meeting to discuss and produce evidence-based recommendations on potential acute and long-term risks, risks to vulnerable populations, the importance for probiotic product quality to match the needs of vulnerable populations, and the need for adverse event reporting related to probiotic use. The importance of whole genome sequencing, which enables determination of virulence, toxin, and antibiotic resistance genes, as well as clear assignment of species and strain identity, is emphasized. We present recommendations to guide the scientific and medical community on judging probiotic safety. Taylor & Francis 2023-03-15 /pmc/articles/PMC10026873/ /pubmed/36919522 http://dx.doi.org/10.1080/19490976.2023.2185034 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Merenstein, Daniel Pot, Bruno Leyer, Gregory Ouwehand, Arthur C. Preidis, Geoffrey A. Elkins, Christopher A. Hill, Colin Lewis, Zachery T. Shane, Andi L. Zmora, Niv Petrova, Mariya I. Collado, Maria Carmen Morelli, Lorenzo Montoya, Gina A. Szajewska, Hania Tancredi, Daniel J. Sanders, Mary Ellen Emerging issues in probiotic safety: 2023 perspectives |
title | Emerging issues in probiotic safety: 2023 perspectives |
title_full | Emerging issues in probiotic safety: 2023 perspectives |
title_fullStr | Emerging issues in probiotic safety: 2023 perspectives |
title_full_unstemmed | Emerging issues in probiotic safety: 2023 perspectives |
title_short | Emerging issues in probiotic safety: 2023 perspectives |
title_sort | emerging issues in probiotic safety: 2023 perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026873/ https://www.ncbi.nlm.nih.gov/pubmed/36919522 http://dx.doi.org/10.1080/19490976.2023.2185034 |
work_keys_str_mv | AT merensteindaniel emergingissuesinprobioticsafety2023perspectives AT potbruno emergingissuesinprobioticsafety2023perspectives AT leyergregory emergingissuesinprobioticsafety2023perspectives AT ouwehandarthurc emergingissuesinprobioticsafety2023perspectives AT preidisgeoffreya emergingissuesinprobioticsafety2023perspectives AT elkinschristophera emergingissuesinprobioticsafety2023perspectives AT hillcolin emergingissuesinprobioticsafety2023perspectives AT lewiszacheryt emergingissuesinprobioticsafety2023perspectives AT shaneandil emergingissuesinprobioticsafety2023perspectives AT zmoraniv emergingissuesinprobioticsafety2023perspectives AT petrovamariyai emergingissuesinprobioticsafety2023perspectives AT colladomariacarmen emergingissuesinprobioticsafety2023perspectives AT morellilorenzo emergingissuesinprobioticsafety2023perspectives AT montoyaginaa emergingissuesinprobioticsafety2023perspectives AT szajewskahania emergingissuesinprobioticsafety2023perspectives AT tancredidanielj emergingissuesinprobioticsafety2023perspectives AT sandersmaryellen emergingissuesinprobioticsafety2023perspectives |